Innovent Biologics, Inc. (IVBXF)
Innovent Biologics Market Cap : 17.47B for Feb. 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CSPC Pharmaceutical Group Ltd. | 14.19B |
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 19.52M |
| Zai Lab Ltd. | 2.018B |
| WuXi Biologics (Cayman), Inc. | 19.81B |
Market Cap Related Metrics
| PS Ratio | 10.76 |
| Price to Free Cash Flow | 123.57 |
| Price | 10.22 |
| Earnings Yield | 0.91% |
| Operating PE Ratio | 69.88 |
| Normalized PE Ratio | 120.09 |